Brian Skorney

Stock Analyst at Baird

(1.04)
# 2079
Out of 5,340 analysts
144
Total ratings
44.44%
Success rate
3.25%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
SLNO Soleno Therapeutics
Maintains: Outperform
102 105
75.51 39.05% 4 May 8, 2025
BIIB Biogen
Maintains: Outperform
300 255
129.5 96.91% 16 May 2, 2025
REGN Regeneron Pharmaceut...
Maintains: Neutral
652 587
596.61 -1.61% 15 Apr 30, 2025
BHVN Biohaven
Maintains: Outperform
60 57
15.74 262.13% 3 Apr 28, 2025
MIRM Mirum Pharmaceutical...
Maintains: Outperform
50 55
44.86 22.6% 5 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
46
11.63 295.53% 1 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
14.03 113.83% 1 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 5
0.45 1011.11% 4 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
5.92 237.84% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 193
37.88 409.5% 7 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 95
106.16 -10.51% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
5.93 321.59% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 10
2.55 292.16% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
215 215
275.84 -22.06% 3 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 180
122.91 46.45% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
3.27 756.27% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 62
30.92 100.52% 4 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 2
n/a n/a 4 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 39
9.79 298.37% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
280 30
n/a n/a 2 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
30.96 103.49% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 173
n/a n/a 8 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 150
n/a n/a 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 18
n/a n/a 5 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 325
440.3 -26.19% 14 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 27
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 55
n/a n/a 4 Oct 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
14.71 -32.02% 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
270
2.54 10529.92% 1 May 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 6
3.43 74.93% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 100
n/a n/a 2 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101
n/a n/a 3 Nov 1, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 300
2.1 14185.71% 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 2 Jan 30, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 14, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 8, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2016